Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

  • Kerr, Peter (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA/ERM Reference Number: 90984
SSA Reference: SSA/90984/MonH-2023-380804(v1)
Monash Health Reference: RES-23-0000-415X
StatusActive
Effective start/end date11/08/23 → 10/08/28

Clinical Trial Phase

  • Phase III (a & b)